Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Akebia Therapeutics (AKBA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 627,386
  • Shares Outstanding, K 56,880
  • Annual Sales, $ 177,980 K
  • Annual Income, $ -76,910 K
  • 36-Month Beta 1.11
  • Price/Sales 3.46
  • Price/Cash Flow N/A
  • Price/Book 3.15

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.30 +18.60%
on 06/04/18
11.24 -1.87%
on 06/15/18
+0.38 (+3.57%)
since 05/18/18
3-Month
8.93 +23.52%
on 05/01/18
12.31 -10.40%
on 03/21/18
-1.13 (-9.29%)
since 03/19/18
52-Week
8.93 +23.52%
on 05/01/18
20.25 -45.53%
on 10/02/17
-3.58 (-24.50%)
since 06/19/17

Most Recent Stories

More News
Investor Expectations to Drive Momentum within Core-Mark Holding, SSR Mining, iRhythm Technologies, Magic Software Enterprises, Jounce Therapeutics, and Akebia Therapeutics -- Discovering Underlying Factors of Influence

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Core-Mark Holding Company,...

CORE : 22.25 (+4.07%)
MGIC : 8.30 (-1.19%)
JNCE : 7.92 (-0.13%)
AKBA : 11.03 (+1.75%)
IRTC : 81.79 (-3.10%)
SSRM : 9.67 (-7.73%)
Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible...

AKBA : 11.03 (+1.75%)
Akebia Therapeut Shares Down 34.5% Since SmarTrend's Sell Call (AKBA)

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on November 9th, 2017 at $15.76. In approximately 6 months, Akebia Therapeut has returned 34.52% as of today's recent price of $10.32....

AKBA : 11.03 (+1.75%)
Akebia Therapeutics Announces First Quarter 2018 Financial Results

Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible...

AKBA : 11.03 (+1.75%)
Akebia Therapeut Down 40.4% Since SmarTrend Downtrend Call (AKBA)

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on November 9th, 2017 at $15.76. In approximately 6 months, Akebia Therapeut has returned 40.36% as of today's recent price of $9.40....

AKBA : 11.03 (+1.75%)
39.9% Return Seen to Date on SmarTrend Akebia Therapeut Call (AKBA)

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on November 9th, 2017 at $15.76. In approximately 6 months, Akebia Therapeut has returned 39.91% as of today's recent price of $9.47....

AKBA : 11.03 (+1.75%)
Akebia Therapeut Down 36.9% Since SmarTrend Downtrend Call (AKBA)

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on November 9th, 2017 at $15.76. In approximately 5 months, Akebia Therapeut has returned 36.87% as of today's recent price of $9.95....

AKBA : 11.03 (+1.75%)
Research Report Identifies Yirendai, Atlantic Capital Bancshares, Jazz Pharmaceuticals, Sina, Akebia Therapeutics, and SMART Global with Renewed Outlook -- Fundamental Analysis, Calculating Forward Movement

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Yirendai Ltd. (NYSE:YRD), Atlantic...

JAZZ : 180.35 (+1.43%)
SGH : 41.22 (-4.54%)
ACBI : 21.20 (+0.95%)
AKBA : 11.03 (+1.75%)
YRD : 22.46 (-3.44%)
SINA : 89.14 (-3.27%)
Akebia Therapeut Has Returned 38.5% Since SmarTrend Recommendation (AKBA)

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on November 9th, 2017 at $15.76. In approximately 5 months, Akebia Therapeut has returned 38.45% as of today's recent price of $9.70....

AKBA : 11.03 (+1.75%)
Akebia Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia-inducible...

AKBA : 11.03 (+1.75%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators are in flux.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade AKBA with:

Business Summary

Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 11.29
1st Resistance Point 11.16
Last Price 11.03
1st Support Level 10.81
2nd Support Level 10.59

See More

52-Week High 20.25
Fibonacci 61.8% 15.93
Fibonacci 50% 14.59
Fibonacci 38.2% 13.25
Last Price 11.03
52-Week Low 8.93

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar